Greg Feero, MD, PhD

Medical School: University of Pittsburgh School of Medicine
Family Medicine Residency: Maine-Dartmouth Family Medicine Residency

Dr. Feero attended the University of Pittsburgh School of Medicine and graduated with an M.D., Ph.D. (Human Genetics) in 1998. He then completed his medical training at the Maine-Dartmouth Family Medicine Residency in Augusta, Maine.  After five years on the faculty of the Maine-Dartmouth Family Medicine Residency, he accepted a position at the National Human Genome Research Institute, National Institutes of Health, where he was a senior advisor to the director, and branch chief of the Genomic Healthcare Branch in the Office of Policy, Communication and Education, Office of the Director. In 2009 he returned to Maine.  Dr. Feero currently serves as a consultant to the Jackson Laboratory on education issues, is an associate editor for the Journal of the American Medical Association and serves on the National Academies of Science, Engineering, and Medicine Roundtable on Genomics and Precision Health. He has authored several book chapters and over 50 peer-reviewed publications and is board certified in family medicine. He is an assistant professor in the Department of Community and Family Medicine at the Geisel School of Medicine at Dartmouth; a clinical associate professor at the University of New England College of Osteopathic Medicine, and a faculty research scientist at Colby College. He currently sees patients at Four Seasons Family Practice in Fairfield, ME.

Additional activities include:

  • Research Director, Maine-Dartmouth Family Medicine Residency, 2009-present
  • Director, Maine-Dartmouth–Colby College Summer Internship Program, 2012-present
  • Member, MaineGeneral Health Institutional Review Board, 2017-present
  • Maine-Dartmouth Family Medicine Residency representative to the Maine Medical Association Legislative Committee, 2017-present
  • Guest editor, “Genomic Medicine” article series, New England Journal of Medicine, 2008-2012

He has authored numerous peer-reviewed and invited publications. His more recent publications include:

Khoury MJ, Feero WG, Chambers DA, Brody LE, Aziz N, Green RC, et al. A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health. PLoS Med 2018;15(8): e1002631.

Feero WG. Genetic factors should be considered when caring for colorectal cancer survivors. Am Fam Physician. 2018;98(8):474-475.

W. Gregory Feero, Wicklund CA, Veenstra D.  Precision medicine, genome sequencing, and improved population health.  JAMA. 2018;319(19):1979-1980.

Feero WG. Is “precision medicine” ready to use in primary care practice?  Yes: It offers patients more individualized ways of managing their health.  American Family Physician. 2017;15(96):767-768.

Feero WG. Introducing “genomics and precision health.” JAMA. 2017;317(18):1842-1843.

Chambers DA, Feero WG, Khoury MJ. Convergence of implementation science, precision medicine, and the learning health care system: A new model for biomedical research. JAMA 2016;315(18):1941-2.

Lowery JT, Ahnen DJ, Schroy PC 3rd, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review. Cancer. 2016;122(17):2633-45.

Chambers DA, Feero WG, Khoury MJ. Convergence of implementation science, precision medicine, and the learning health care system: A new model for biomedical research. JAMA. 2016;315(18):1941-2.

Filipski KK, Pacanowski MA, Ramamoorthy A, Feero WG, Freedman AN. Dosing recommendations for pharmacogenetic interactions related to drug metabolism. Pharmacogenet Genomics. 2016;26(7):334-9.

Feero WG. Establishing the clinical validity of arrhythmia-related genetic variations using the electronic medical record: A valid take on precision medicine? JAMA. 2016;315(1):33-5.

David SP, Johnson SG, Berger AC, Feero WG, Terry SF, Green LA, Phillips RL Jr, Ginsburg GS. Making Personalized Health Care Even More Personalized: Insights From Activities of the IOM Genomics Roundtable. Ann Fam Med. 2015;13(4):373-80

Feero WG, Facio FM, Glogowski EA, Hampel HL, Stopfer JE, Eidem H, Pizzino AM, Barton DK, Biesecker LG. Preliminary validation of a consumer-oriented colorectal cancer risk assessment tool compatible with the US Surgeon General’s My Family Health Portrait. Genet Med. 2015;17(9):753-6.

Ulm E, Feero WG, Dineen R, Charrow J, Wicklund C. Genetics professionals’ opinions of whole-genome sequencing in the newborn period. J Genet Couns. 2015;24(3):452-63.

Feero WG, Manolio TA, Khoury MJ. Translational research is a key to nongeneticist physicians’ genomics education. Genet Med. 2014;16(12):871-3.

Feero WG. Clinical application of whole-genome sequencing: proceed with care. JAMA. 2014;311(10):1017-9.

Edelman EA, Lin BK, Doksum T, Drohan B, Edelson V, Dolan SM, Hughes KS, O’Leary J, Galvin SL, Degroat N, Pardanani S, Feero WG, Adams C, Jones R, Scott J. Implementation of an electronic genomic and family health history tool in primary prenatal care. Am J Med Genet C Semin Med Genet. 2014;166C(1):34-44.

Dotson WD, Douglas MP, Kolor K, Stewart AC, Bowen MS, Gwinn M, Wulf A, Anders HM, Chang CQ, Clyne M, Lam TK, Schully SD, Marrone M, Feero WG, Khoury MJ. Prioritizing genomic applications for action by level of evidence: a horizon-scanning method. Clin Pharmacol Ther. 2014;95(4):394-402

Feero WG, Guttmacher AE. Genomics, personalized medicine, and pediatrics. Acad Pediatr. 2014;14(1):14-22.